The majority of new prostate cancer cases currently occur in elderly men (54% in men aged ≥ 65 in 2012). By 2030, there is expected to be a
188% increase in the number of new prostate cancer cases, 58% of which will affect men aged ≥ 65. Similar increases are expected for other
cancers, namely gastric cancer, pancreatic cancer, and hepatocellular carcinoma, with a predominance in men and women aged ≥ 65.